Molecular circuits of resolution in the eye

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 1029-1047

  Liclican, Elvira L ^a   Gronert, Karsten ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3 polyunsaturated fatty acids; Inflammatory resolution; Lipoxin A4; Lipoxygenase; Neuroprotectin D1; Resolvins

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; AUTACOID; CYCLOOXYGENASE 2; CYTOCHROME P450; DOCOSAHEXAENOIC ACID; HEME OXYGENASE 1; HEME OXYGENASE 2; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LEUKOTRIENE; LIPOXIN A; MUCIN; NEUROPROTECTIN D1; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN F2 ALPHA; RESOLVINS; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; CELL MIGRATION; CONJUNCTIVA; CORNEA; DRY EYE; EYE INFLAMMATION; GENE DELETION; HOST RESISTANCE; HUMAN; KERATITIS; LYMPHOCYTE; MACROPHAGE; MOLECULAR DYNAMICS; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; OPTICAL RESOLUTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN SECRETION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; UVEITIS; WOUND HEALING; ANIMAL; EYE; LIPID METABOLISM; METABOLISM;

MUS;

ANIMALS; EYE; HUMANS; LIPID METABOLISM;

EID: 77955872825     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.99     Document Type: Review

References (202)

1. Kaplan, H.J. (2007) Anatomy and function of the eye. Chem. Immunol. Allergy 92, 4-10.
2. Streilein, J.W. (1995) Unraveling immune privilege. Science 270, 1158-1159.
3. Streilein, J.W. (2003a) Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J. Leukoc. Biol. 74, 179-185.
4. Streilein, J.W. (2003b) Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3, 879-889.
5. McDermott, A.M., Perez, V., Huang, A.J., Pflugfelder, S.C., Stern, M.E., Baudouin, C., Beuerman, R.W., Burns, A.R., Calder, V.L., Calonge, M., Chodosh, J., Coster, D.J., Dana, R., Hazlett, L.D., Jones, D.B., Kim, S.K., Knop, E., Li, D.Q., Mitchell, B.M., Niederkorn, J.Y., Pearlman, E., Wilhelmus, K.R., and Kurie, E. (2005) Pathways of corneal and ocular surface inflammation: a perspective from the cullen symposium. Ocul. Surf. 3, S131-138.
6. Gronert, K. (2008) Lipid autacoids in inflammation and injury responses: a matter of privilege. Mol. Interv. 8, 28-35.
7. Niederkorn, J.Y. (2006) See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat. Immunol. 7, 354-359.
8. Kumar, V., Fausto, N., and Abbas, A. (2004) Robbins and Cotran Pathological Basis of Disease. W.B. Saunders, Philadelphia.
9. Ono, S.J. (2003) Immunity in the eye: lessons in organ-specific responses. J. Leukoc. Biol. 74, 149-150.
10. Kaplan, H.J. and Niederkorn, J.Y. (2007) Regional immunity and immune privilege. Chem. Immunol. Allergy 92, 11-26.
11. Niederkorn, J.Y. and Kaplan, H.J. (2007) Rationale for immune response and the eye. Chem. Immunol. Allergy 92, 1-3.
12. Hamrah, P., Huq, S.O., Liu, Y., Zhang, Q., and Dana, M.R. (2003) Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J. Leukoc. Biol. 74, 172-178.
13. Niederkorn, J.Y. (2003) The immune privilege of corneal grafts. J. Leukoc. Biol. 74, 167-171.
14. Leopold, I.H. and Gaster, R.N. (1988) Ocular Inflammation and Anti-Inflammatory Drugs. Churchill Livingston, New York.
15. Waring, G.O., 3rd and Rodrigues, M.M. (1987) Patterns of pathologic response in the cornea. Surv. Ophthalmol. 31, 262-266.
16. Gronert, K. (2005) Lipoxins in the eye and their role in wound healing. Prostaglandins Leukot. Essent. Fatty Acids 73, 221-229.
17. Cursiefen, C. (2007) Immune privilege and angiogenic privilege of the cornea. Chem. Immunol. Allergy 92, 50-57.
18. Bazan, H. and Ottino, P. (2002) The role of platelet-activating factor in the corneal response to injury. Prog. Retin. Eye Res. 21, 449-464.
19. Bazan, H.E. (2005) Cellular and molecular events in corneal wound healing: significance of lipid signalling. Exp. Eye Res. 80, 453-463.
20. Bazan, N.G. (2006) Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci. 29, 263-271.
21. Laniado-Schwartzman, M. and Dunn, M.W. (2003) Cytochrome P450-derived eicosanoids mediators of ocular surface inflammation. Adv. Exp. Med. Biol. 525, 47-54.
22. Bazan, H.E. (1987) Corneal injury alters eicosanoid formation in the rabbit anterior segment in vivo. Invest. Ophthalmol. Vis. Sci. 28, 314-319.
23. Bazan, H.E., Birkle, D.L., Beuerman, R.W., and Bazan, N.G. (1985) Inflammation-induced stimulation of the synthesis of prostaglandins and lipoxygenase-reaction products in rabbit cornea. Curr. Eye Res. 4, 175-179.
24. Tjebbes, G.W., van Delft, J.L., and van Haeringen, N.J. (1993) Production of lipid mediators in experimental keratitis of rabbit eye. J. Lipid Mediat. 8, 87-93.
25. Talahalli, R., Zarini, S., Sheibani, N., Murphy, R.C., and Gubitosi-Klug, R.A. (2009) Elevated glucose increases synthesis of leukotrienes in the mouse model of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci.
26. Kulkarni, P.S. and Srinivasan, B.D. (1989) Cyclooxygenase and lipoxygenase pathways in anterior uvea and conjunctiva. Prog. Clin. Biol. Res. 312, 39-52.
27. Eakins, K.E., Whitelocke, R.A., Perkins, E.S., Bennett, A., and Unger, W.G. (1972) Release of prostaglandins in ocular inflammation in the rabbit. Nat. New Biol. 239, 248-249.
28. Bito, L.Z. (2001) A new approach to the medical management of glaucoma, from the bench to the clinic, and beyond: the Proctor Lecture. Invest. Ophthalmol. Vis. Sci. 42, 1126-1133.
29. Srinivasan, B.D. and Kulkarni, P.S. (1989) Inhibitors of Arachidonic Acid Cascades in the Management of Ocular Inflammation. Alan R. Liss, New York.
30. Camras, C.B., Bito, L.Z., and Eakins, K.E. (1977) Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits. Invest. Ophthalmol. Vis. Sci. 16, 1125-1134.
31. Bartlett, J.D. and Jaanus, S.D. (2008) Clinical Ocular Pharmacology. Butterworth-Heinemann, St. Louis.
32. Bito, L.Z. (1986) Prostaglandins and other eicosanoids: their ocular transport, pharmacokinetics, and therapeutic effects. Trans. Ophthalmol. Soc. U. K. 105(Pt 2), 162-170.
33. Bazan, H.E. (1989) The Synthesis and Effects of Eicosanoids in Avascular Ocular Tissues. Alan R. Liss, New York.
34. Bazan, N.G. and Allan, G. (1997) Signal transduction and gene expression in the eye: a contemporary view of the pro-inflammatory, anti-inflammatory and modulatory roles of prostaglandins and other bioactive lipids. Surv. Ophthalmol. 41(Suppl 2), S23-34.
35. Hurst, J.S. and Bazan, H.E. (1995) Activation of the phospholipase/ cyclooxygenase cascade in the rabbit cornea by platelet-activating factor is challenged by PAF receptor antagonists. J. Ocul. Pharmacol. Ther. 11, 329-337.
36. Kenchgowda, S. and Bazan, H.E. (2010) Significance of lipid mediators in corneal injury and repair. J. Lipid Res. 51, 879-891.
37. Biswas, S., Bhattacherjee, P., Paterson, C.A., Maruyama, T., and Narumiya, S. (2007) Modulation of ocular inflammatory responses by EP1 receptors in mice. Exp. Eye Res. 84, 39-43.
38. Biswas, S., Bhattacherjee, P., Paterson, C.A., Tilley, S.L., and Koller, B.H. (2006) Ocular inflammatory responses in the EP2 and EP4 receptor knockout mice. Ocul. Immunol. Inflamm. 14, 157-163.
39. Baranano, D.E., Kim, S.J., Edelhauser, H.F., Durairaj, C., Kompella, U.B., and Handa, J.T. (2009) Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation. Br. J. Ophthalmol. 93, 1387-1390.
40. Ueda, M., Sugatani, J., Unezaki, S., Ito, Y., Miki, H., Uyama, M., and Ito, S. (1997) Involvement of prostaglandin E2 in rabbit corneal injury by anterior segment ischaemia. Prostaglandins Leukot. Essent. Fatty Acids 57, 285-291.
41. Biswas, S., Bhattacherjee, P., and Paterson, C.A. (2004) Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues - a comparative immunohistochemical study. Prostaglandins Leukot. Essent. Fatty Acids 71, 277-288.
42. Serhan, C.N., Brain, S.D., Buckley, C.D., Gilroy, D.W., Haslett, C., O'Neill, L.A., Perretti, M., Rossi, A.G., and Wallace, J.L. (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325-332.
43. Tilley, S.L., Coffman, T.M., and Koller, B.H. (2001) Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108, 15-23.
44. Huang, S.K., White, E.S., Wettlaufer, S.H., Grifka, H., Hogaboam, C.M., Thannickal, V.J., Horowitz, J.C., and Peters-Golden, M. (2009) Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways. FASEB J. 23, 4317-4326.
45. Sandulache, V.C., Parekh, A., Li-Korotky, H.S., Dohar, J.E., and Hebda, P.A. (2006) Prostaglandin E2 differentially modulates human fetal and adult dermal fibroblast migration and contraction: implication for wound healing. Wound Repair Regen. 14, 633-643.
46. Wang, D. and Dubois, R.N. (2006) Prostaglandins and cancer. Gut 55, 115-122.
47. Samuelsson, B., Morgenstern, R., and Jakobsson, P.J. (2007) Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol. Rev. 59, 207-224.
48. Harris, S.G., Padilla, J., Koumas, L., Ray, D., and Phipps, R.P. (2002) Prostaglandins as modulators of immunity. Trends Immunol. 23, 144-150.
49. Rajakariar, R., Yaqoob, M.M., and Gilroy, D.W. (2006) COX-2 in inflammation and resolution. Mol. Interv. 6, 199-207.
50. Gilroy, D.W., Lawrence, T., Perretti, M., and Rossi, A.G. (2004) Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug Discov. 3, 401-416.
51. Rajakariar, R., Hilliard, M., Lawrence, T., Trivedi, S., Colville-Nash, P., Bellingan, G., Fitzgerald, D., Yaqoob, M.M., and Gilroy, D.W. (2007) Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. Proc. Natl. Acad. Sci. U. S. A. 104, 20979-20984.
52. Zhuang, H., Pin, S., Li, X., and Dore, S. (2003) Regulation of heme oxygenase expression by cyclopentenone prostaglandins. Exp. Biol. Med. (Maywood) 228, 499-505.
53. Lee, T.S., Tsai, H.L., and Chau, L.Y. (2003) Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12,14-prostaglandin J2. J. Biol. Chem. 278, 19325-19330.
54. Gilroy, D.W., Colville-Nash, P.R., Willis, D., Chivers, J., Paul-Clark, M.J., and Willoughby, D.A. (1999) Inducible cycloxygenase may have anti-inflammatory properties. Nat. Med. 5, 698-701.
55. Colville-Nash, P.R., Gilroy, D.W., Willis, D., Paul-Clark, M.J., Moore, A.R., and Willoughby, D.A. (2005) Prostaglandin F2alpha produced by inducible cyclooxygenase may contribute to the resolution of inflammation. Inflammopharmacology 12, 473-476; discussion 477-480.
56. Gilroy, D.W., Colville-Nash, P.R., McMaster, S., Sawatzky, D.A., Willoughby, D.A., and Lawrence, T. (2003) Inducible cyclooxygenase-derived 15-deoxy(Delta)12-14PGJ2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis. FASEB J. 17, 2269-2271.
57. Bazan, N.G. (1989a) Metabolism of arachidonic acid in the retina and retinal pigment epithelium: biological effects of oxygenated metabolites of arachidonic acid. Prog. Clin. Biol. Res. 312, 15-37.
58. Bazan, N.G. (1989b) The metabolism of omega-3 polyunsaturated fatty acids in the eye: the possible role of docosahexaenoic acid and docosanoids in retinal physiology and ocular pathology. Prog. Clin. Biol. Res. 312, 95-112.
59. Augustin, A.J., Grus, F.H., Koch, F., and Spitznas, M. (1997) Detection of eicosanoids in epiretinal membranes of patients suffering from proliferative vitreoretinal diseases. Br. J. Ophthalmol. 81, 58-60.
60. Qin, Q., Patil, K.A., Gronert, K., and Sharma, S.C. (2008) Neuroprotectin D1 inhibits retinal ganglion cell death following axotomy. Prostaglandins Leukot. Essent. Fatty Acids 79, 201-207.
61. Haque, M.S., Arora, J.K., Dikdan, G., Lysz, T.W., and Zelenka, P.S. (1999) The rabbit lens epithelial cell line N/N1003A requires 12-lipoxygenase activity for DNA synthesis in response to EGF. Mol. Vis. 5, 8.
62. Arora, J.K., Lysz, T.W., and Zelenka, P.S. (1996) A role for 12(S)-HETE in the response of human lens epithelial cells to epidermal growth factor and insulin. Invest. Ophthalmol. Vis. Sci. 37, 1411-1418.
63. van Leyen, K., Duvoisin, R.M., Engelhardt, H., and Wiedmann, M. (1998) A function for lipoxygenase in programmed organelle degradation. Nature 395, 392-395.
64. Hurst, J.S., Balazy, M., Bazan, H.E., and Bazan, N.G. (1991) The epithelium, endothelium, and stroma of the rabbit cornea generate (12S)-hydroxyeicosatetraenoic acid as the main lipoxygenase metabolite in response to injury. J. Biol. Chem. 266, 6726-6730.
65. Chang, M.S., Schneider, C., Roberts, R.L., Shappell, S.B., Haselton, F.R., Boeglin, W.E., and Brash, A.R. (2005) Detection and subcellular localization of two 15S-lipoxygenases in human cornea. Invest. Ophthalmol. Vis. Sci. 46, 849-856.
66. Liminga, M., Hornsten, L., Sprecher, H.W., and Oliw, E.H. (1994) Arachidonate 15-lipoxygenase in human corneal epithelium and 12- and 15-lipoxygenases in bovine corneal epithelium: comparison with other bovine 12-lipoxygenases. Biochim. Biophys. Acta 1210, 288-296.
67. Yamada, M. and Proia, A.D. (2000) 8(S)-hydroxyeicosatetraenoic acid is the lipoxygenase metabolite of arachidonic acid that regulates epithelial cell migration in the rat cornea. Cornea 19, S13-20.
68. Brash, A.R., Boeglin, W.E., and Chang, M.S. (1997) Discovery of a second 15S-lipoxygenase in humans. Proc. Natl. Acad. Sci. U. S. A. 94, 6148-6152.
69. Liminga, M., Von Malmborg, A., and Oliw, E. (1994) Lipoxygenases in human, monkey, and bovine corneal epithelia. Ann. N. Y. Acad. Sci. 744, 317-319. (Pubitemid 26005836)
70. Liminga, M. and Oliw, E. (1999) cDNA cloning of 15-lipoxygenase type 2 and 12-lipoxygenases of bovine corneal epithelium. Biochim. Biophys. Acta 1437, 124-135.
71. Liminga, M., Fagerholm, P., and Oliw, E.H. (1994) Lipoxygenases in corneal epithelia of man and cynomolgus monkey. Exp. Eye Res. 59, 313-321. (Pubitemid 24326995)
72. Funk, C.D., Keeney, D.S., Oliw, E.H., Boeglin, W.E., and Brash, A.R. (1996) Functional expression and cellular localization of a mouse epidermal lipoxygenase. J. Biol. Chem. 271, 23338-23344.
73. Chen, X.S., Kurre, U., Jenkins, N.A., Copeland, N.G., and Funk, C.D. (1994) cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure, and chromosomal localizations of murine 12-lipoxygenases. J. Biol. Chem. 269, 13979-13987.
74. Funk, C.D., Chen, X.S., Johnson, E.N., and Zhao, L. (2002) Lipoxygenase genes and their targeted disruption. Prostaglandins Other Lipid Mediat. 68-69, 303-312.
75. McDonnell, M., Davis, W., Jr., Li, H., and Funk, C.D. (2001) Characterization of the murine epidermal 12/15-lipoxygenase. Prostaglandins Other Lipid Mediat. 63, 93-107.
76. Gronert, K., Maheshwari, N., Khan, N., Hassan, I.R., Dunn, M., and Laniado Schwartzman, M. (2005) A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 280, 15267-15278.
77. Calandria, J.M., Marcheselli, V.L., Mukherjee, P.K., Uddin, J., Winkler, J.W., Petasis, N.A., and Bazan, N.G. (2009) Selective survival rescue in 15-lipoxygenase-1-deficient retinal pigment epithelial cells by the novel docosahexaenoic acid-derived mediator, neuroprotectin D1. J. Biol. Chem. 284, 17877-17882.
78. Roman, R.J. (2002) P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol. Rev. 82, 131-185.
79. Maier, K.G. and Roman, R.J. (2001) Cytochrome P450 metabolites of arachidonic acid in the control of renal function. Curr. Opin. Nephrol. Hypertens. 10, 81-87.
80. Zhou, S.F., Liu, J.P., and Chowbay, B. (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab. Rev. 41, 89-295.
81. Roman, R.J., Maier, K.G., Sun, C.W., Harder, D.R., and Alonso-Galicia, M. (2000) Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids. Clin. Exp. Pharmacol. Physiol. 27, 855-865.
82. McGiff, J.C. and Quilley, J. (2001) 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr. Opin. Nephrol. Hypertens. 10, 231-237.
83. Fleming, I. (2001) Cytochrome p450 and vascular homeostasis. Circ. Res. 89, 753-762.
84. Schwartzman, M.L. (1997) Cytochrome P450 and Arachidonic Acid Metabolism in the Corneal Epithelium: Role in Inflammation. Plenum Press, New York.
85. Fleming, I. (2008) Vascular cytochrome p450 enzymes: physiology and pathophysiology. Trends Cardiovasc. Med. 18, 20-25.
86. Gauthier, K.M., Yang, W., Gross, G.J., and Campbell, W.B. (2007) Roles of epoxyeicosatrienoic acids in vascular regulation and cardiac preconditioning. J. Cardiovasc. Pharmacol. 50, 601-608.
87. Campbell, W.B. (2000) New role for epoxyeicosatrienoic acids as anti-inflammatory mediators. Trends Pharmacol. Sci. 21, 125-127.
88. Vasiliou, V. and Gonzalez, F.J. (2008) Role of CYP1B1 in glaucoma. Annu. Rev. Pharmacol. Toxicol. 48, 333-358.
89. Michaelis, U.R., Xia, N., Barbosa-Sicard, E., Falck, J.R., and Fleming, I. (2008) Role of cytochrome P450 2C epoxygenases in hypoxia-induced cell migration and angiogenesis in retinal endothelial cells. Invest. Ophthalmol. Vis. Sci. 49, 1242-1247.
90. Seta, F., Patil, K., Bellner, L., Mezentsev, A., Kemp, R., Dunn, M.W., and Schwartzman, M.L. (2007) Inhibition of VEGF expression and corneal neovascularization by siRNA targeting cytochrome P450 4B1. Prostaglandins Other Lipid Mediat. 84, 116-127.
91. Claria, J., Lee, M.H., and Serhan, C.N. (1996) Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol. Med. 2, 583-596.
92. Serhan, C.N. and Chiang, N. (2002) Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins. TheScientificWorldJOURNAL 2, 169-204.
93. Stafforini, D.M., McIntyre, T.M., Zimmerman, G.A., and Prescott, S.M. (2003) Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit. Rev. Clin. Lab. Sci. 40, 643-672.
94. Hanahan, D.J. (1986) Platelet activating factor: a biologically active phosphoglyceride. Annu. Rev. Biochem. 55, 483-509.
95. Snyder, F. (1990) Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am. J. Physiol. 259, C697-708.
96. Esquenazi, S., He, J., Bazan, H.E., and Bazan, N.G. (2004) Prevention of experimental diffuse lamellar keratitis using a novel platelet-activating factor receptor antagonist. J. Cataract Refract. Surg. 30, 884-891.
97. Esquenazi, S., He, J., Li, N., Bazan, N.G., Esquenazi, I., and Bazan, H.E. (2009) A novel platelet activating factor receptor antagonist reduces cell infiltration and expression of inflammatory mediators in mice exposed to desiccating conditions after PRK. Clin. Dev. Immunol. 2009, 138513.
98. Schwab, J.M., Chiang, N., Arita, M., and Serhan, C.N. (2007) Resolvin E1 and protectin D1 activate inflammationresolution programmes. Nature 447, 869-874.
99. Serhan, C.N. and Savill, J. (2005) Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191-1197.
100. Serhan, C.N., Chiang, N., and Van Dyke, T.E. (2008) Resolving inflammation: dual anti-inflammatory and proresolution lipid mediators. Nat. Rev. Immunol. 8, 349-361.
101. Serhan, C.N. and Chiang, N. (2008) Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br. J. Pharmacol. 153(Suppl 1), S200-215.
102. Serhan, C.N., Hamberg, M., and Samuelsson, B. (1984) Trihydroxytetraenes: a novel series of compounds formed from arachidonic acid in human leukocytes. Biochem. Biophys. Res. Commun. 118, 943-949. (Pubitemid 14194804)
103. Serhan, C.N. (2002) Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat. 68-69, 433-455.
104. Lawrence, T., Willoughby, D.A., and Gilroy, D.W. (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2, 787-795.
105. McMahon, B., Mitchell, S., Brady, H.R., and Godson, C. (2001) Lipoxins: revelations on resolution. Trends Pharmacol. Sci. 22, 391-395.
106. Maderna, P. and Godson, C. (2009) Lipoxins: resolutionary road. Br. J. Pharmacol. 158, 947-959.
107. Kuhn, H. and O'Donnell, V.B. (2006) Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 45, 334-356.
108. McMahon, B. and Godson, C. (2004) Lipoxins: endogenous regulators of inflammation. Am. J. Physiol. Renal Physiol. 286, F189-201.
109. Chiang, N., Serhan, C.N., Dahlen, S.E., Drazen, J.M., Hay, D.W., Rovati, G.E., Shimizu, T., Yokomizo, T., and Brink, C. (2006) The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 58, 463-487.
110. Serhan, C.N. (2007) Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25, 101-137.
111. Jozsef, L., Zouki, C., Petasis, N.A., Serhan, C.N., and Filep, J.G. (2002) Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc. Natl. Acad. Sci. U. S. A. 99, 13266-13271.
112. Parkinson, J.F. (2006) Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation. Inflamm. Allergy Drug Targets 5, 91-106.
113. Ariel, A., Chiang, N., Arita, M., Petasis, N.A., and Serhan, C.N. (2003) Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. J. Immunol. 170, 6266-6272.
114. Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C.N., and Sher, A. (2002) Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 3, 76-82.
115. Gronert, K., Gewirtz, A., Madara, J.L., and Serhan, C.N. (1998) Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J. Exp. Med. 187, 1285-1294.
116. Biteman, B., Hassan, I.R., Walker, E., Leedom, A.J., Dunn, M., Seta, F., Laniado-Schwartzman, M., and Gronert, K. (2007) Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing. FASEB J. 21, 2257-2266.
117. Simpson, D.M. and Ross, R. (1972) The neutrophilic leukocyte in wound repair a study with antineutrophil serum. J. Clin. Invest. 51, 2009-2023.
118. Gan, L., Fagerholm, P., and Kim, H.J. (1999) Effect of leukocytes on corneal cellular proliferation and wound healing. Invest. Ophthalmol. Vis. Sci. 40, 575-581.
119. Vij, N., Roberts, L., Joyce, S., and Chakravarti, S. (2005) Lumican regulates corneal inflammatory responses by modulating Fas-Fas ligand signaling. Invest. Ophthalmol. Vis. Sci. 46, 88-95.
120. Li, Z., Burns, A.R., and Smith, C.W. (2006) Two waves of neutrophil emigration in response to corneal epithelial abrasion: distinct adhesion molecule requirements. Invest. Ophthalmol. Vis. Sci. 47, 1947-1955.
121. Li, Z., Rumbaut, R.E., Burns, A.R., and Smith, C.W. (2006) Platelet response to corneal abrasion is necessary for acute inflammation and efficient re-epithelialization. Invest. Ophthalmol. Vis. Sci. 47, 4794-4802.
122. Petrescu, M.S., Larry, C.L., Bowden, R.A., Williams, G.W., Gagen, D., Li, Z., Smith, C.W., and Burns, A.R. (2007) Neutrophil interactions with keratocytes during corneal epithelial wound healing: a role for CD18 integrins. Invest. Ophthalmol. Vis. Sci. 48, 5023-5029.
123. Cubitt, C.L., Tang, Q., Monteiro, C.A., Lausch, R.N., and Oakes, J.E. (1993) IL-8 gene expression in cultures of human corneal epithelial cells and keratocytes. Invest. Ophthalmol. Vis. Sci. 34, 3199-3206.
124. Rosenbaum, J.T., Planck, S.T., Huang, X.N., Rich, L., and Ansel, J.C. (1995) Detection of mRNA for the cytokines, interleukin-1 alpha and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy. Invest. Ophthalmol. Vis. Sci. 36, 2151-2155.
125. Spandau, U.H., Toksoy, A., Verhaart, S., Gillitzer, R., and Kruse, F.E. (2003) High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo. Arch. Ophthalmol. 121, 825-831.
126. Otterbein, L.E., Soares, M.P., Yamashita, K., and Bach, F.H. (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24, 449-455.
127. Hanselmann, C., Mauch, C., and Werner, S. (2001) Haem oxygenase-1: a novel player in cutaneous wound repair and psoriasis? Biochem. J. 353, 459-466.
128. Hegazi, R.A., Rao, K.N., Mayle, A., Sepulveda, A.R., Otterbein, L.E., and Plevy, S.E. (2005) Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J. Exp. Med. 202, 1703-1713.
129. Ryter, S.W., Alam, J., and Choi, A.M. (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86, 583-650.
130. Song, R., Kubo, M., Morse, D., Zhou, Z., Zhang, X., Dauber, J.H., Fabisiak, J., Alber, S.M., Watkins, S.C., Zuckerbraun, B.S., Otterbein, L.E., Ning, W., Oury, T.D., Lee, P.J., McCurry, K.R., and Choi, A.M. (2003) Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am. J. Pathol. 163, 231-242.
131. Seta, F., Bellner, L., Rezzani, R., Regan, R.F., Dunn, M.W., Abraham, N.G., Gronert, K., and Laniado-Schwartzman, M. (2006) Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response. Am. J. Pathol. 169, 1612-1623.
132. Bellner, L., Vitto, M., Patil, K.A., Dunn, M.W., Regan, R., and Laniado-Schwartzman, M. (2008) Exacerbated corneal inflammation and neovascularization in the HO-2 null mice is ameliorated by biliverdin. Exp. Eye Res. 87, 268-278.
133. Nascimento-Silva, V., Arruda, M.A., Barja-Fidalgo, C., Villela, C.G., and Fierro, I.M. (2005) Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells. Am. J. Physiol. Cell Physiol. 289, C557-563.
134. Medeiros, R., Rodrigues, G.B., Figueiredo, C.P., Rodrigues, E.B., Grumman, A., Jr., Menezes-de-Lima, O., Jr., Passos, G.F., and Calixto, J.B. (2008) Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis. Mol. Pharmacol. 74, 154-161.
135. Leedom, A.J., Sullivan, A.B., Dong, B., Lau, D., and Gronert, K. (2010) Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury. Am. J. Pathol. 176, 74-84.
136. Jin, Y., Arita, M., Zhang, Q., Saban, D.R., Chauhan, S.K., Chiang, N., Serhan, C.N., and Dana, R. (2009) Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest. Ophthalmol. Vis. Sci. 50, 4743-4752.
137. De Caterina, R., Endres, S., Kristensen, S.D., and Schmidt, E.B., Eds. (1993) n-3 Fatty Acids and Vascular Disease. Springer-Verlag, London.
138. Simopoulos, A.P., Leaf, A., and Salem, N., Jr. (1999) Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J. Am. Coll. Nutr. 18, 487-489. (Pubitemid 29455723)
139. Simopoulos, A.P. (1991) Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 54, 438-463.
140. Simopoulos, A.P. (1999) Essential fatty acids in health and chronic disease. Am J Clin Nutr 70, 560S-569S.
141. Burr, G.O. and Burr, M.M. (1973) Nutrition classics from The Journal of Biological Chemistry 82:345-67, 1929. A new deficiency disease produced by the rigid exclusion of fat from the diet. Nutr. Rev. 31, 248-249.
142. (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354, 447-455.
143. Bazan, N.G., Marcheselli, V.L., and Cole-Edwards, K. (2005) Brain response to injury and neurodegeneration: endogenous neuroprotective signaling. Ann. N. Y. Acad. Sci. 1053, 137-147.
144. Harris, W.S., Mozaffarian, D., Lefevre, M., Toner, C.D., Colombo, J., Cunnane, S.C., Holden, J.M., Klurfeld, D.M., Morris, M.C., and Whelan, J. (2009) Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J. Nutr. 139, 804S-819S.
145. Kromann, N. and Green, A. (1980) Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. Acta Med. Scand. 208, 401-406.
146. Gronert, K. and Hassan, I.R. (2007) Reaping the benefits of renal protective lipid autacoids. Drug Discov. Today Dis. Mech. 4, 3-10.
147. Mori, T.A. (2006) Omega-3 fatty acids and hypertension in humans. Clin. Exp. Pharmacol. Physiol. 33, 842-846.
148. Blok, W.L., Katan, M.B., and van der Meer, J.W. (1996) Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J. Nutr. 126, 1515-1533.
149. Simopoulos, A.P. (2002) Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 21, 495-505.
150. Tomobe, Y.I., Morizawa, K., Tsuchida, M., Hibino, H., Nakano, Y., and Tanaka, Y. (2000) Dietary docosahexaenoic acid suppresses inflammation and immunoresponses in contact hypersensitivity reaction in mice. Lipids 35, 61-69.
151. James, M.J., Gibson, R.A., and Cleland, L.G. (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 71, 343S-348S.
152. Hibbeln, J.R., Nieminen, L.R., Blasbalg, T.L., Riggs, J.A., and Lands, W.E. (2006) Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am. J. Clin. Nutr. 83, 1483S-1493S.
153. De Caterina, R., Liao, J.K., and Libby, P. (2000) Fatty acid modulation of endothelial activation. Am. J. Clin. Nutr.71, 213S-223S.
154. Bazan, N.G. (2009) Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins Leukot. Essent. Fatty Acids 81, 205-211.
155. Simopoulos, A.P. (2009) Omega-6/omega-3 essential fatty acids: biological effects. World Rev. Nutr. Diet 99, 1-16.
156. Mukherjee, P.K., Chawla, A., Loayza, M.S., and Bazan, N.G. (2007) Docosanoids are multifunctional regulators of neural cell integrity and fate: significance in aging and disease. Prostaglandins Leukot. Essent. Fatty Acids 77, 233-238.
157. Hodge, W.G., Barnes, D., Schachter, H.M., Pan, Y.I., Lowcock, E.C., Zhang, L., Sampson, M., Morrison, A., Tran, K., Miguelez, M., and Lewin, G. (2006) The evidence for efficacy of omega-3 fatty acids in preventing or slowing the progression of retinitis pigmentosa: a systematic review. Can. J. Ophthalmol. 41, 481-490.
158. Hodge, W.G., Barnes, D., Schachter, H.M., Pan, Y.I., Lowcock, E.C., Zhang, L., Sampson, M., Morrison, A., Tran, K., Miguelez, M., and Lewin, G. (2007) Evidence for the effect of omega-3 fatty acids on progression of age-related macular degeneration: a systematic review. Retina 27, 216-221.
159. Hodge, W.G., Schachter, H.M., Barnes, D., Pan, Y., Lowcock, E.C., Zhang, L., Sampson, M., Morrison, A., Tran, K., Miguelez, M., and Lewin, G. (2006) Efficacy of omega-3 fatty acids in preventing age-related macular degeneration: a systematic review. Ophthalmology 113, 1165-1172; quiz 1172-1163, 1178.
160. Tuo, J., Ross, R.J., Herzlich, A.A., Shen, D., Ding, X., Zhou, M., Coon, S.L., Hussein, N., Salem, N., Jr., and Chan, C.C. (2009) A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. Am. J. Pathol. 175, 799-807.
161. Connor, K.M., SanGiovanni, J.P., Lofqvist, C., Aderman, C.M., Chen, J., Higuchi, A., Hong, S., Pravda, E.A., Majchrzak, S., Carper, D., Hellstrom, A., Kang, J.X., Chew, E.Y., Salem, N., Jr., Serhan, C.N., and Smith, L.E. (2007) Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 13, 868-873.
162. SanGiovanni, J.P., Parra-Cabrera, S., Colditz, G.A., Berkey, C.S., and Dwyer, J.T. (2000) Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 105, 1292-1298.
163. SanGiovanni, J.P., Berkey, C.S., Dwyer, J.T., and Colditz, G.A. (2000) Dietary essential fatty acids, long-chain polyunsaturated fatty acids, and visual resolution acuity in healthy fullterm infants: a systematic review. Early Hum. Dev. 57, 165-188.
164. SanGiovanni, J.P., Chew, E.Y., Clemons, T.E., Davis, M.D., Ferris, F.L., 3rd, Gensler, G.R., Kurinij, N., Lindblad, A.S., Milton, R.C., Seddon, J.M., and Sperduto, R.D. (2007) The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch. Ophthalmol. 125, 671-679.
165. SanGiovanni, J.P., Chew, E.Y., Agron, E., Clemons, T.E., Ferris, F.L., 3rd, Gensler, G., Lindblad, A.S., Milton, R.C., Seddon, J.M., Klein, R., and Sperduto, R.D. (2008) The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS Report No. 23. Arch. Ophthalmol. 126, 1274-1279.
166. Sangiovanni, J.P., Agron, E., Meleth, A.D., Reed, G.F., Sperduto, R.D., Clemons, T.E., and Chew, E.Y. (2009) {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS Report 30, a prospective cohort study from the Age-Related Eye Disease Study. Am. J. Clin. Nutr. 90, 1601-1607.
167. Miljanovic, B., Trivedi, K.A., Dana, M.R., Gilbard, J.P., Buring, J.E., and Schaumberg, D.A. (2005) Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am. J. Clin. Nutr. 82, 887-893.
168. Rashid, S., Jin, Y., Ecoiffier, T., Barabino, S., Schaumberg, D.A., and Dana, M.R. (2008) Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch. Ophthalmol. 126, 219-225.
169. Hong, S., Gronert, K., Devchand, P.R., Moussignac, R.L., and Serhan, C.N. (2003) Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 278, 14677-14687.
170. Serhan, C.N., Yacoubian, S., and Yang, R. (2008) Anti-inflammatory and proresolving lipid mediators. Annu. Rev. Pathol. 3, 279-312.
171. Serhan, C.N. (2006) Resolution phases of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25, 101-137.
172. Ariel, A. and Serhan, C.N. (2007) Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 28, 176-183.
173. Marcheselli, V.L., Hong, S., Lukiw, W.J., Tian, X.H., Gronert, K., Musto, A., Hardy, M., Gimenez, J.M., Chiang, N., Serhan, C.N., and Bazan, N.G. (2003) Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278, 43807-43817.
174. Bazan, N.G. (2007) Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr. Opin. Clin. Nutr. Metab. Care 10, 136-141.
175. Bazan, N.G. (2009) Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. J. Lipid Res. 50(Suppl), S400-405.
176. Spite, M., Norling, L.V., Summers, L., Yang, R., Cooper, D., Petasis, N.A., Flower, R.J., Perretti, M., and Serhan, C.N. (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287-1291.
177. Sun, Y.P., Oh, S.F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S.P., Petasis, N.A., and Serhan, C.N. (2007) Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem. 282, 9323-9334.
178. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N.A., and Serhan, C.N. (2005) Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201, 713-722.
179. Serhan, C.N., Gotlinger, K., Hong, S., Lu, Y., Siegelman, J., Baer, T., Yang, R., Colgan, S.P., and Petasis, N.A. (2006) Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176, 1848-1859.
180. Arterburn, L.M., Hall, E.B., and Oken, H. (2006) Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 83, 1467S-1476S.
181. Aveldano, M.I. and Bazan, N.G. (1983) Molecular species of phosphatidylcholine, -ethanolamine, -serine, and - inositol in microsomal and photoreceptor membranes of bovine retina. J. Lipid Res. 24, 620-627.
182. Choe, H.G. and Anderson, R.E. (1990) Unique molecular species composition of glycerolipids of frog rod outer segments. Exp. Eye Res. 51, 159-165.
183. Fliesler, S.J. and Anderson, R.E. (1983) Chemistry and metabolism of lipids in the vertebrate retina. Prog. Lipid Res. 22, 79-131.
184. Neuringer, M., Connor, W.E., Lin, D.S., Barstad, L., and Luck, S. (1986) Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc. Natl. Acad. Sci. U. S. A. 83, 4021-4025.
185. Marszalek, J.R. and Lodish, H.F. (2005) Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: breastmilk and fish are good for you. Annu. Rev. Cell Dev. Biol. 21, 633-657.
186. SanGiovanni, J.P. and Chew, E.Y. (2005) The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog. Retin. Eye Res. 24, 87-138.
187. Neuringer, M., Connor, W.E., Van Petten, C., and Barstad, L. (1984) Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys. J. Clin. Invest. 73, 272-276.
188. Stinson, A.M., Wiegand, R.D., and Anderson, R.E. (1991) Recycling of docosahexaenoic acid in rat retinas during n-3 fatty acid deficiency. J. Lipid Res. 32, 2009-2017.
189. Ebert, S., Weigelt, K., Walczak, Y., Drobnik, W., Mauerer, R., Hume, D.A., Weber, B.H., and Langmann, T. (2009) Docosahexaenoic acid attenuates microglial activation and delays early retinal degeneration. J. Neurochem. 110, 1863-1875.
190. Zamiri, P., Sugita, S., and Streilein, J.W. (2007) Immunosuppressive properties of the pigmented epithelial cells and the subretinal space. Chem. Immunol. Allergy 92, 86-93.
191. Bazan, N.G. (2008) Neurotrophins induce neuroprotective signaling in the retinal pigment epithelial cell by activating the synthesis of the anti-inflammatory and anti-apoptotic neuroprotectin D1. Adv. Exp. Med. Biol. 613, 39-44.
192. Mukherjee, P.K., Marcheselli, V.L., de Rivero Vaccari, J.C., Gordon, W.C., Jackson, F.E., and Bazan, N.G. (2007) Photoreceptor outer segment phagocytosis attenuates oxidative stress-induced apoptosis with concomitant neuroprotectin D1 synthesis. Proc. Natl. Acad. Sci. U. S. A. 104, 13158-13163.
193. Mukherjee, P.K., Marcheselli, V.L., Serhan, C.N., and Bazan, N.G. (2004) Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 101, 8491-8496.
194. Tian, H., Lu, Y., Sherwood, A.M., Hongqian, D., and Hong, S. (2009) Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. Invest. Ophthalmol. Vis. Sci. 50, 3613-3620.
195. Zhang, F., Chen, N., Pan, Z., Gjorstrup, P., and Reinach, P.S. (2008) Resolvins stimulate human corneal epithelial cell migration. Invest. Ophthalmol. Vis. Sci. 49, E-Abstract 3396.
196. Zhang, F., Yang, H., Gjorstrup, P., and Reinach, P. (2009) Cell signaling pathways underlying resolvin induced increases in human corneal epithelial cell migration: effects of RX-10001 (RvE1) and RX-10008. Invest. Ophthalmol. Vis. Sci. 50, E-Abstract 3492.
197. Li, N., He, J., Gjorstrup, P., and Bazan, H.E. (2008) The resolvin E1 analogs, RX-10065 and RX-1005 improve tear production and decrease inflammation in a mouse dry eye model. Invest. Ophthalmol. Vis. Sci. 121, E-Abstract 148.
198. Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J.N., Petasis, N.A., Blumberg, R.S., and Serhan, C.N. (2005) Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. U. S. A. 102, 7671-7676.
199. Haworth, O., Cernadas, M., Yang, R., Serhan, C.N., and Levy, B.D. (2008) Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat. Immunol. 9, 873-879.
200. He, J. and Bazan, H.E. (2010) Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery. Prostaglandins Leukot. Essent. Fatty Acids 82, 319-325.
201. Cortina, M.S., He, J., Li, N., Bazan, N.G., and Bazan, H.E. (2010) Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA. Invest. Ophthalmol. Vis. Sci. 51, 804-810.
202. Esquenazi, S., Bazan, H.E., Bui, V., He, J., Kim, D.B., and Bazan, N.G. (2005) Topical combination of NGF and DHA increases rabbit corneal nerve regeneration after photorefractive keratectomy. Invest. Ophthalmol. Vis. Sci. 46, 3121-3127.